Lymphohaematopoietic growth factors in cancer therapy
Author(s)
Bibliographic Information
Lymphohaematopoietic growth factors in cancer therapy
（Monographs / European School of Oncology）
Springer-Verlag, c1990
- : gw
- : us
Available at 1 libraries
Description and Table of Contents
Description
Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the "ESO Monographs" series. The discussion revolves around the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research.
Table of Contents
- Interleukins and haematopoietic growth factors
- mechanisms of T-cell activation
- characteristics of LAK cells and their use in adoptive therapy of cancer in experimental animals
- interleukin 2 - in vivo induction of effector cells
- cellular immunotherapy of cancer - the use of lymphokine-activated natural killer (LANAK) cells
- interleukin 2 - clinical aspects
- interleukin 2 and LAK cells.
by "Nielsen BookData"